Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 29, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Cash Flow Hedging Instruments

At September 29, 2024, October 1, 2023 and December 31, 2023, the notional amounts and fair values of the Company's foreign currency forward contracts designated as cash flow hedging instruments were as follows:

	September 29, 2024				October 1, 2023				December 31, 2023
Hedged transaction	Notional Amount		Fair Value		Notional Amount		Fair Value		Notional Amount		Fair Value
Inventory purchases	$	164.7	$	1.3	$	194.4	$	3.4	$	129.9	$	(1.7)
Sales	104.6		(3.2)		113.4		0.8		89.7		(0.2)
Royalties and Other	26.4		1.5		70.5		(0.9)		31.7		(0.5)
Total	$	295.7	$	(0.4)	$	378.3	$	3.3	$	251.3	$	(2.4)

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The fair values of the Company's foreign currency forward contracts designated as cash flow hedges are recorded in the Consolidated Balance Sheets at September 29, 2024, October 1, 2023 and December 31, 2023 as follows:

	September 29, 2024		October 1, 2023		December 31, 2023
Prepaid expenses and other current assets
Unrealized gains	$	3.1	$	5.9	$	0.5
Unrealized losses	(0.2)		(2.0)		(0.1)
Net unrealized gains	$	2.9	$	3.9	$	0.4
Other assets
Unrealized gains	$	0.5	$	1.5	$	—
Unrealized losses	—		(0.1)		—
Net unrealized gains	$	0.5	$	1.4	$	—
Accrued liabilities
Unrealized gains	$	1.0	$	0.4	$	0.7
Unrealized losses	(4.0)		(2.4)		(3.5)
Net unrealized losses	$	(3.0)	$	(2.0)	$	(2.8)
Other liabilities
Unrealized gains	$	0.1	$	—	$	—
Unrealized losses	(1.0)		—		—
Net unrealized losses	$	(0.9)	$	—	$	—

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations

Net gains (losses) on cash flow hedging activities have been reclassified from other comprehensive earnings (loss) to net earnings for the three and nine months ended September 29, 2024 and October 1, 2023 as follows:

	Three Months Ended				Nine Months Ended
	September 29, 2024		October 1, 2023		September 29, 2024		October 1, 2023
Statements of Operations Classification
Cost of sales	$	(0.6)	$	1.8	$	(0.7)	$	0.5
Net revenues	0.8		(0.1)		1.4		(0.2)
Other	(0.3)		1.2		—		1.7
Net realized (losses) gains	$	(0.1)	$	2.9	$	0.7	$	2.0

Schedule of Fair Values of Undesignated Derivative Financial Instruments

At September 29, 2024, October 1, 2023 and December 31, 2023, the fair values of the Company's undesignated derivative financial instruments were recorded in the Consolidated Balance Sheets as follows:

	September 29, 2024		October 1, 2023		December 31, 2023
Prepaid expenses and other current assets
Unrealized gains	$	—	$	10.7	$	0.3
Unrealized losses	—		(7.7)		—
Net unrealized gains	$	—	$	3.0	$	0.3
Accrued liabilities
Unrealized gains	$	0.2	$	—	$	1.4
Unrealized losses	(2.2)		(0.1)		(2.5)
Net unrealized losses	$	(2.0)	$	(0.1)	$	(1.1)